Global Leuprolide Market Growth (Status and Outlook) 2025-2031
According to this study, the global Leuprolide market size will reach US$ million by 2031.
Leuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer's disease.
United States market for Leuprolide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Leuprolide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Leuprolide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Leuprolide players cover TOLMAR PHARMACEUTICALS, Sanofi, Teva, Sandoz (Novartis), Sun Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Leuprolide Industry Forecast” looks at past sales and reviews total world Leuprolide sales in 2024, providing a comprehensive analysis by region and market sector of projected Leuprolide sales for 2025 through 2031. With Leuprolide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Leuprolide industry.
This Insight Report provides a comprehensive analysis of the global Leuprolide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Leuprolide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Leuprolide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Leuprolide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Leuprolide.
This report presents a comprehensive overview, market shares, and growth opportunities of Leuprolide market by product type, application, key players and key regions and countries.
Segmentation by Type:
Leuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer's disease.
United States market for Leuprolide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Leuprolide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Leuprolide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Leuprolide players cover TOLMAR PHARMACEUTICALS, Sanofi, Teva, Sandoz (Novartis), Sun Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Leuprolide Industry Forecast” looks at past sales and reviews total world Leuprolide sales in 2024, providing a comprehensive analysis by region and market sector of projected Leuprolide sales for 2025 through 2031. With Leuprolide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Leuprolide industry.
This Insight Report provides a comprehensive analysis of the global Leuprolide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Leuprolide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Leuprolide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Leuprolide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Leuprolide.
This report presents a comprehensive overview, market shares, and growth opportunities of Leuprolide market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Subcutaneous
- Topical
- Breast Cancer
- Endometriosis
- Precocious Puberty
- Prostate Cancer
- Uterine Fibrosis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- TOLMAR PHARMACEUTICALS
- Sanofi
- Teva
- Sandoz (Novartis)
- Sun Pharmaceutical
- AbbVie
- Bayer
- Takeda
- Beijing Boente Pharmaceutical
- Livzon Pharmaceutical
- Selleck
- Hangzhou Peptide Biochemical
- Chengdu Shenguo Biological Pharmaceutical
- SciAnda Pharma
- Daewoong
- GP Pharm
- Enteris BioPharma
- Chong Kun Dang
- Leadiant Biosciences
- Hikma Pharmaceuticals
- Lee Pharma
- Hanall
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Leuprolide Market Size (2020-2031)
2.1.2 Leuprolide Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Leuprolide by Country/Region (2020, 2024 & 2031)
2.2 Leuprolide Segment by Type
2.2.1 Subcutaneous
2.2.2 Topical
2.3 Leuprolide Market Size by Type
2.3.1 Leuprolide Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Leuprolide Market Size Market Share by Type (2020-2025)
2.4 Leuprolide Segment by Application
2.4.1 Breast Cancer
2.4.2 Endometriosis
2.4.3 Precocious Puberty
2.4.4 Prostate Cancer
2.4.5 Uterine Fibrosis
2.4.6 Other
2.5 Leuprolide Market Size by Application
2.5.1 Leuprolide Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Leuprolide Market Size Market Share by Application (2020-2025)
3 LEUPROLIDE MARKET SIZE BY PLAYER
3.1 Leuprolide Market Size Market Share by Player
3.1.1 Global Leuprolide Revenue by Player (2020-2025)
3.1.2 Global Leuprolide Revenue Market Share by Player (2020-2025)
3.2 Global Leuprolide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LEUPROLIDE BY REGION
4.1 Leuprolide Market Size by Region (2020-2025)
4.2 Global Leuprolide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Leuprolide Market Size Growth (2020-2025)
4.4 APAC Leuprolide Market Size Growth (2020-2025)
4.5 Europe Leuprolide Market Size Growth (2020-2025)
4.6 Middle East & Africa Leuprolide Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Leuprolide Market Size by Country (2020-2025)
5.2 Americas Leuprolide Market Size by Type (2020-2025)
5.3 Americas Leuprolide Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Leuprolide Market Size by Region (2020-2025)
6.2 APAC Leuprolide Market Size by Type (2020-2025)
6.3 APAC Leuprolide Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Leuprolide Market Size by Country (2020-2025)
7.2 Europe Leuprolide Market Size by Type (2020-2025)
7.3 Europe Leuprolide Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Leuprolide by Region (2020-2025)
8.2 Middle East & Africa Leuprolide Market Size by Type (2020-2025)
8.3 Middle East & Africa Leuprolide Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LEUPROLIDE MARKET FORECAST
10.1 Global Leuprolide Forecast by Region (2026-2031)
10.1.1 Global Leuprolide Forecast by Region (2026-2031)
10.1.2 Americas Leuprolide Forecast
10.1.3 APAC Leuprolide Forecast
10.1.4 Europe Leuprolide Forecast
10.1.5 Middle East & Africa Leuprolide Forecast
10.2 Americas Leuprolide Forecast by Country (2026-2031)
10.2.1 United States Market Leuprolide Forecast
10.2.2 Canada Market Leuprolide Forecast
10.2.3 Mexico Market Leuprolide Forecast
10.2.4 Brazil Market Leuprolide Forecast
10.3 APAC Leuprolide Forecast by Region (2026-2031)
10.3.1 China Leuprolide Market Forecast
10.3.2 Japan Market Leuprolide Forecast
10.3.3 Korea Market Leuprolide Forecast
10.3.4 Southeast Asia Market Leuprolide Forecast
10.3.5 India Market Leuprolide Forecast
10.3.6 Australia Market Leuprolide Forecast
10.4 Europe Leuprolide Forecast by Country (2026-2031)
10.4.1 Germany Market Leuprolide Forecast
10.4.2 France Market Leuprolide Forecast
10.4.3 UK Market Leuprolide Forecast
10.4.4 Italy Market Leuprolide Forecast
10.4.5 Russia Market Leuprolide Forecast
10.5 Middle East & Africa Leuprolide Forecast by Region (2026-2031)
10.5.1 Egypt Market Leuprolide Forecast
10.5.2 South Africa Market Leuprolide Forecast
10.5.3 Israel Market Leuprolide Forecast
10.5.4 Turkey Market Leuprolide Forecast
10.6 Global Leuprolide Forecast by Type (2026-2031)
10.7 Global Leuprolide Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Leuprolide Forecast
11 KEY PLAYERS ANALYSIS
11.1 TOLMAR PHARMACEUTICALS
11.1.1 TOLMAR PHARMACEUTICALS Company Information
11.1.2 TOLMAR PHARMACEUTICALS Leuprolide Product Offered
11.1.3 TOLMAR PHARMACEUTICALS Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 TOLMAR PHARMACEUTICALS Main Business Overview
11.1.5 TOLMAR PHARMACEUTICALS Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Leuprolide Product Offered
11.2.3 Sanofi Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Leuprolide Product Offered
11.3.3 Teva Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Information
11.4.2 Sandoz (Novartis) Leuprolide Product Offered
11.4.3 Sandoz (Novartis) Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sandoz (Novartis) Main Business Overview
11.4.5 Sandoz (Novartis) Latest Developments
11.5 Sun Pharmaceutical
11.5.1 Sun Pharmaceutical Company Information
11.5.2 Sun Pharmaceutical Leuprolide Product Offered
11.5.3 Sun Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Sun Pharmaceutical Main Business Overview
11.5.5 Sun Pharmaceutical Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Leuprolide Product Offered
11.6.3 AbbVie Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Leuprolide Product Offered
11.7.3 Bayer Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Leuprolide Product Offered
11.8.3 Takeda Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Beijing Boente Pharmaceutical
11.9.1 Beijing Boente Pharmaceutical Company Information
11.9.2 Beijing Boente Pharmaceutical Leuprolide Product Offered
11.9.3 Beijing Boente Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Beijing Boente Pharmaceutical Main Business Overview
11.9.5 Beijing Boente Pharmaceutical Latest Developments
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Information
11.10.2 Livzon Pharmaceutical Leuprolide Product Offered
11.10.3 Livzon Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Livzon Pharmaceutical Main Business Overview
11.10.5 Livzon Pharmaceutical Latest Developments
11.11 Selleck
11.11.1 Selleck Company Information
11.11.2 Selleck Leuprolide Product Offered
11.11.3 Selleck Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Selleck Main Business Overview
11.11.5 Selleck Latest Developments
11.12 Hangzhou Peptide Biochemical
11.12.1 Hangzhou Peptide Biochemical Company Information
11.12.2 Hangzhou Peptide Biochemical Leuprolide Product Offered
11.12.3 Hangzhou Peptide Biochemical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Hangzhou Peptide Biochemical Main Business Overview
11.12.5 Hangzhou Peptide Biochemical Latest Developments
11.13 Chengdu Shenguo Biological Pharmaceutical
11.13.1 Chengdu Shenguo Biological Pharmaceutical Company Information
11.13.2 Chengdu Shenguo Biological Pharmaceutical Leuprolide Product Offered
11.13.3 Chengdu Shenguo Biological Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Chengdu Shenguo Biological Pharmaceutical Main Business Overview
11.13.5 Chengdu Shenguo Biological Pharmaceutical Latest Developments
11.14 SciAnda Pharma
11.14.1 SciAnda Pharma Company Information
11.14.2 SciAnda Pharma Leuprolide Product Offered
11.14.3 SciAnda Pharma Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 SciAnda Pharma Main Business Overview
11.14.5 SciAnda Pharma Latest Developments
11.15 Daewoong
11.15.1 Daewoong Company Information
11.15.2 Daewoong Leuprolide Product Offered
11.15.3 Daewoong Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Daewoong Main Business Overview
11.15.5 Daewoong Latest Developments
11.16 GP Pharm
11.16.1 GP Pharm Company Information
11.16.2 GP Pharm Leuprolide Product Offered
11.16.3 GP Pharm Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 GP Pharm Main Business Overview
11.16.5 GP Pharm Latest Developments
11.17 Enteris BioPharma
11.17.1 Enteris BioPharma Company Information
11.17.2 Enteris BioPharma Leuprolide Product Offered
11.17.3 Enteris BioPharma Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Enteris BioPharma Main Business Overview
11.17.5 Enteris BioPharma Latest Developments
11.18 Chong Kun Dang
11.18.1 Chong Kun Dang Company Information
11.18.2 Chong Kun Dang Leuprolide Product Offered
11.18.3 Chong Kun Dang Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Chong Kun Dang Main Business Overview
11.18.5 Chong Kun Dang Latest Developments
11.19 Leadiant Biosciences
11.19.1 Leadiant Biosciences Company Information
11.19.2 Leadiant Biosciences Leuprolide Product Offered
11.19.3 Leadiant Biosciences Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Leadiant Biosciences Main Business Overview
11.19.5 Leadiant Biosciences Latest Developments
11.20 Hikma Pharmaceuticals
11.20.1 Hikma Pharmaceuticals Company Information
11.20.2 Hikma Pharmaceuticals Leuprolide Product Offered
11.20.3 Hikma Pharmaceuticals Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Hikma Pharmaceuticals Main Business Overview
11.20.5 Hikma Pharmaceuticals Latest Developments
11.21 Lee Pharma
11.21.1 Lee Pharma Company Information
11.21.2 Lee Pharma Leuprolide Product Offered
11.21.3 Lee Pharma Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Lee Pharma Main Business Overview
11.21.5 Lee Pharma Latest Developments
11.22 Hanall
11.22.1 Hanall Company Information
11.22.2 Hanall Leuprolide Product Offered
11.22.3 Hanall Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Hanall Main Business Overview
11.22.5 Hanall Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Leuprolide Market Size (2020-2031)
2.1.2 Leuprolide Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Leuprolide by Country/Region (2020, 2024 & 2031)
2.2 Leuprolide Segment by Type
2.2.1 Subcutaneous
2.2.2 Topical
2.3 Leuprolide Market Size by Type
2.3.1 Leuprolide Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Leuprolide Market Size Market Share by Type (2020-2025)
2.4 Leuprolide Segment by Application
2.4.1 Breast Cancer
2.4.2 Endometriosis
2.4.3 Precocious Puberty
2.4.4 Prostate Cancer
2.4.5 Uterine Fibrosis
2.4.6 Other
2.5 Leuprolide Market Size by Application
2.5.1 Leuprolide Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Leuprolide Market Size Market Share by Application (2020-2025)
3 LEUPROLIDE MARKET SIZE BY PLAYER
3.1 Leuprolide Market Size Market Share by Player
3.1.1 Global Leuprolide Revenue by Player (2020-2025)
3.1.2 Global Leuprolide Revenue Market Share by Player (2020-2025)
3.2 Global Leuprolide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LEUPROLIDE BY REGION
4.1 Leuprolide Market Size by Region (2020-2025)
4.2 Global Leuprolide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Leuprolide Market Size Growth (2020-2025)
4.4 APAC Leuprolide Market Size Growth (2020-2025)
4.5 Europe Leuprolide Market Size Growth (2020-2025)
4.6 Middle East & Africa Leuprolide Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Leuprolide Market Size by Country (2020-2025)
5.2 Americas Leuprolide Market Size by Type (2020-2025)
5.3 Americas Leuprolide Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Leuprolide Market Size by Region (2020-2025)
6.2 APAC Leuprolide Market Size by Type (2020-2025)
6.3 APAC Leuprolide Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Leuprolide Market Size by Country (2020-2025)
7.2 Europe Leuprolide Market Size by Type (2020-2025)
7.3 Europe Leuprolide Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Leuprolide by Region (2020-2025)
8.2 Middle East & Africa Leuprolide Market Size by Type (2020-2025)
8.3 Middle East & Africa Leuprolide Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LEUPROLIDE MARKET FORECAST
10.1 Global Leuprolide Forecast by Region (2026-2031)
10.1.1 Global Leuprolide Forecast by Region (2026-2031)
10.1.2 Americas Leuprolide Forecast
10.1.3 APAC Leuprolide Forecast
10.1.4 Europe Leuprolide Forecast
10.1.5 Middle East & Africa Leuprolide Forecast
10.2 Americas Leuprolide Forecast by Country (2026-2031)
10.2.1 United States Market Leuprolide Forecast
10.2.2 Canada Market Leuprolide Forecast
10.2.3 Mexico Market Leuprolide Forecast
10.2.4 Brazil Market Leuprolide Forecast
10.3 APAC Leuprolide Forecast by Region (2026-2031)
10.3.1 China Leuprolide Market Forecast
10.3.2 Japan Market Leuprolide Forecast
10.3.3 Korea Market Leuprolide Forecast
10.3.4 Southeast Asia Market Leuprolide Forecast
10.3.5 India Market Leuprolide Forecast
10.3.6 Australia Market Leuprolide Forecast
10.4 Europe Leuprolide Forecast by Country (2026-2031)
10.4.1 Germany Market Leuprolide Forecast
10.4.2 France Market Leuprolide Forecast
10.4.3 UK Market Leuprolide Forecast
10.4.4 Italy Market Leuprolide Forecast
10.4.5 Russia Market Leuprolide Forecast
10.5 Middle East & Africa Leuprolide Forecast by Region (2026-2031)
10.5.1 Egypt Market Leuprolide Forecast
10.5.2 South Africa Market Leuprolide Forecast
10.5.3 Israel Market Leuprolide Forecast
10.5.4 Turkey Market Leuprolide Forecast
10.6 Global Leuprolide Forecast by Type (2026-2031)
10.7 Global Leuprolide Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Leuprolide Forecast
11 KEY PLAYERS ANALYSIS
11.1 TOLMAR PHARMACEUTICALS
11.1.1 TOLMAR PHARMACEUTICALS Company Information
11.1.2 TOLMAR PHARMACEUTICALS Leuprolide Product Offered
11.1.3 TOLMAR PHARMACEUTICALS Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 TOLMAR PHARMACEUTICALS Main Business Overview
11.1.5 TOLMAR PHARMACEUTICALS Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Leuprolide Product Offered
11.2.3 Sanofi Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Leuprolide Product Offered
11.3.3 Teva Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Information
11.4.2 Sandoz (Novartis) Leuprolide Product Offered
11.4.3 Sandoz (Novartis) Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sandoz (Novartis) Main Business Overview
11.4.5 Sandoz (Novartis) Latest Developments
11.5 Sun Pharmaceutical
11.5.1 Sun Pharmaceutical Company Information
11.5.2 Sun Pharmaceutical Leuprolide Product Offered
11.5.3 Sun Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Sun Pharmaceutical Main Business Overview
11.5.5 Sun Pharmaceutical Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Leuprolide Product Offered
11.6.3 AbbVie Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Leuprolide Product Offered
11.7.3 Bayer Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Leuprolide Product Offered
11.8.3 Takeda Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Beijing Boente Pharmaceutical
11.9.1 Beijing Boente Pharmaceutical Company Information
11.9.2 Beijing Boente Pharmaceutical Leuprolide Product Offered
11.9.3 Beijing Boente Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Beijing Boente Pharmaceutical Main Business Overview
11.9.5 Beijing Boente Pharmaceutical Latest Developments
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Information
11.10.2 Livzon Pharmaceutical Leuprolide Product Offered
11.10.3 Livzon Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Livzon Pharmaceutical Main Business Overview
11.10.5 Livzon Pharmaceutical Latest Developments
11.11 Selleck
11.11.1 Selleck Company Information
11.11.2 Selleck Leuprolide Product Offered
11.11.3 Selleck Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Selleck Main Business Overview
11.11.5 Selleck Latest Developments
11.12 Hangzhou Peptide Biochemical
11.12.1 Hangzhou Peptide Biochemical Company Information
11.12.2 Hangzhou Peptide Biochemical Leuprolide Product Offered
11.12.3 Hangzhou Peptide Biochemical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Hangzhou Peptide Biochemical Main Business Overview
11.12.5 Hangzhou Peptide Biochemical Latest Developments
11.13 Chengdu Shenguo Biological Pharmaceutical
11.13.1 Chengdu Shenguo Biological Pharmaceutical Company Information
11.13.2 Chengdu Shenguo Biological Pharmaceutical Leuprolide Product Offered
11.13.3 Chengdu Shenguo Biological Pharmaceutical Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Chengdu Shenguo Biological Pharmaceutical Main Business Overview
11.13.5 Chengdu Shenguo Biological Pharmaceutical Latest Developments
11.14 SciAnda Pharma
11.14.1 SciAnda Pharma Company Information
11.14.2 SciAnda Pharma Leuprolide Product Offered
11.14.3 SciAnda Pharma Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 SciAnda Pharma Main Business Overview
11.14.5 SciAnda Pharma Latest Developments
11.15 Daewoong
11.15.1 Daewoong Company Information
11.15.2 Daewoong Leuprolide Product Offered
11.15.3 Daewoong Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Daewoong Main Business Overview
11.15.5 Daewoong Latest Developments
11.16 GP Pharm
11.16.1 GP Pharm Company Information
11.16.2 GP Pharm Leuprolide Product Offered
11.16.3 GP Pharm Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 GP Pharm Main Business Overview
11.16.5 GP Pharm Latest Developments
11.17 Enteris BioPharma
11.17.1 Enteris BioPharma Company Information
11.17.2 Enteris BioPharma Leuprolide Product Offered
11.17.3 Enteris BioPharma Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Enteris BioPharma Main Business Overview
11.17.5 Enteris BioPharma Latest Developments
11.18 Chong Kun Dang
11.18.1 Chong Kun Dang Company Information
11.18.2 Chong Kun Dang Leuprolide Product Offered
11.18.3 Chong Kun Dang Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Chong Kun Dang Main Business Overview
11.18.5 Chong Kun Dang Latest Developments
11.19 Leadiant Biosciences
11.19.1 Leadiant Biosciences Company Information
11.19.2 Leadiant Biosciences Leuprolide Product Offered
11.19.3 Leadiant Biosciences Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Leadiant Biosciences Main Business Overview
11.19.5 Leadiant Biosciences Latest Developments
11.20 Hikma Pharmaceuticals
11.20.1 Hikma Pharmaceuticals Company Information
11.20.2 Hikma Pharmaceuticals Leuprolide Product Offered
11.20.3 Hikma Pharmaceuticals Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Hikma Pharmaceuticals Main Business Overview
11.20.5 Hikma Pharmaceuticals Latest Developments
11.21 Lee Pharma
11.21.1 Lee Pharma Company Information
11.21.2 Lee Pharma Leuprolide Product Offered
11.21.3 Lee Pharma Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Lee Pharma Main Business Overview
11.21.5 Lee Pharma Latest Developments
11.22 Hanall
11.22.1 Hanall Company Information
11.22.2 Hanall Leuprolide Product Offered
11.22.3 Hanall Leuprolide Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Hanall Main Business Overview
11.22.5 Hanall Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Leuprolide Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Leuprolide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Subcutaneous
Table 4. Major Players of Topical
Table 5. Leuprolide Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Leuprolide Market Size Market Share by Type (2020-2025)
Table 8. Leuprolide Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Leuprolide Market Size Market Share by Application (2020-2025)
Table 11. Global Leuprolide Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Leuprolide Revenue Market Share by Player (2020-2025)
Table 13. Leuprolide Key Players Head office and Products Offered
Table 14. Leuprolide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Leuprolide Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Leuprolide Market Size Market Share by Region (2020-2025)
Table 19. Global Leuprolide Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Leuprolide Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Leuprolide Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Leuprolide Market Size Market Share by Country (2020-2025)
Table 23. Americas Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Leuprolide Market Size Market Share by Type (2020-2025)
Table 25. Americas Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Leuprolide Market Size Market Share by Application (2020-2025)
Table 27. APAC Leuprolide Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Leuprolide Market Size Market Share by Region (2020-2025)
Table 29. APAC Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Leuprolide Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Leuprolide Market Size Market Share by Country (2020-2025)
Table 33. Europe Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Leuprolide Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Leuprolide
Table 39. Key Market Challenges & Risks of Leuprolide
Table 40. Key Industry Trends of Leuprolide
Table 41. Global Leuprolide Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Leuprolide Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Leuprolide Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Leuprolide Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. TOLMAR PHARMACEUTICALS Details, Company Type, Leuprolide Area Served and Its Competitors
Table 46. TOLMAR PHARMACEUTICALS Leuprolide Product Offered
Table 47. TOLMAR PHARMACEUTICALS Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. TOLMAR PHARMACEUTICALS Main Business
Table 49. TOLMAR PHARMACEUTICALS Latest Developments
Table 50. Sanofi Details, Company Type, Leuprolide Area Served and Its Competitors
Table 51. Sanofi Leuprolide Product Offered
Table 52. Sanofi Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sanofi Main Business
Table 54. Sanofi Latest Developments
Table 55. Teva Details, Company Type, Leuprolide Area Served and Its Competitors
Table 56. Teva Leuprolide Product Offered
Table 57. Teva Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Teva Main Business
Table 59. Teva Latest Developments
Table 60. Sandoz (Novartis) Details, Company Type, Leuprolide Area Served and Its Competitors
Table 61. Sandoz (Novartis) Leuprolide Product Offered
Table 62. Sandoz (Novartis) Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sandoz (Novartis) Main Business
Table 64. Sandoz (Novartis) Latest Developments
Table 65. Sun Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 66. Sun Pharmaceutical Leuprolide Product Offered
Table 67. Sun Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sun Pharmaceutical Main Business
Table 69. Sun Pharmaceutical Latest Developments
Table 70. AbbVie Details, Company Type, Leuprolide Area Served and Its Competitors
Table 71. AbbVie Leuprolide Product Offered
Table 72. AbbVie Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. AbbVie Main Business
Table 74. AbbVie Latest Developments
Table 75. Bayer Details, Company Type, Leuprolide Area Served and Its Competitors
Table 76. Bayer Leuprolide Product Offered
Table 77. Bayer Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Bayer Main Business
Table 79. Bayer Latest Developments
Table 80. Takeda Details, Company Type, Leuprolide Area Served and Its Competitors
Table 81. Takeda Leuprolide Product Offered
Table 82. Takeda Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Takeda Main Business
Table 84. Takeda Latest Developments
Table 85. Beijing Boente Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 86. Beijing Boente Pharmaceutical Leuprolide Product Offered
Table 87. Beijing Boente Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Beijing Boente Pharmaceutical Main Business
Table 89. Beijing Boente Pharmaceutical Latest Developments
Table 90. Livzon Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 91. Livzon Pharmaceutical Leuprolide Product Offered
Table 92. Livzon Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Livzon Pharmaceutical Main Business
Table 94. Livzon Pharmaceutical Latest Developments
Table 95. Selleck Details, Company Type, Leuprolide Area Served and Its Competitors
Table 96. Selleck Leuprolide Product Offered
Table 97. Selleck Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Selleck Main Business
Table 99. Selleck Latest Developments
Table 100. Hangzhou Peptide Biochemical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 101. Hangzhou Peptide Biochemical Leuprolide Product Offered
Table 102. Hangzhou Peptide Biochemical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Hangzhou Peptide Biochemical Main Business
Table 104. Hangzhou Peptide Biochemical Latest Developments
Table 105. Chengdu Shenguo Biological Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 106. Chengdu Shenguo Biological Pharmaceutical Leuprolide Product Offered
Table 107. Chengdu Shenguo Biological Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Chengdu Shenguo Biological Pharmaceutical Main Business
Table 109. Chengdu Shenguo Biological Pharmaceutical Latest Developments
Table 110. SciAnda Pharma Details, Company Type, Leuprolide Area Served and Its Competitors
Table 111. SciAnda Pharma Leuprolide Product Offered
Table 112. SciAnda Pharma Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. SciAnda Pharma Main Business
Table 114. SciAnda Pharma Latest Developments
Table 115. Daewoong Details, Company Type, Leuprolide Area Served and Its Competitors
Table 116. Daewoong Leuprolide Product Offered
Table 117. Daewoong Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Daewoong Main Business
Table 119. Daewoong Latest Developments
Table 120. GP Pharm Details, Company Type, Leuprolide Area Served and Its Competitors
Table 121. GP Pharm Leuprolide Product Offered
Table 122. GP Pharm Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. GP Pharm Main Business
Table 124. GP Pharm Latest Developments
Table 125. Enteris BioPharma Details, Company Type, Leuprolide Area Served and Its Competitors
Table 126. Enteris BioPharma Leuprolide Product Offered
Table 127. Enteris BioPharma Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Enteris BioPharma Main Business
Table 129. Enteris BioPharma Latest Developments
Table 130. Chong Kun Dang Details, Company Type, Leuprolide Area Served and Its Competitors
Table 131. Chong Kun Dang Leuprolide Product Offered
Table 132. Chong Kun Dang Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Chong Kun Dang Main Business
Table 134. Chong Kun Dang Latest Developments
Table 135. Leadiant Biosciences Details, Company Type, Leuprolide Area Served and Its Competitors
Table 136. Leadiant Biosciences Leuprolide Product Offered
Table 137. Leadiant Biosciences Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Leadiant Biosciences Main Business
Table 139. Leadiant Biosciences Latest Developments
Table 140. Hikma Pharmaceuticals Details, Company Type, Leuprolide Area Served and Its Competitors
Table 141. Hikma Pharmaceuticals Leuprolide Product Offered
Table 142. Hikma Pharmaceuticals Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Hikma Pharmaceuticals Main Business
Table 144. Hikma Pharmaceuticals Latest Developments
Table 145. Lee Pharma Details, Company Type, Leuprolide Area Served and Its Competitors
Table 146. Lee Pharma Leuprolide Product Offered
Table 147. Lee Pharma Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Lee Pharma Main Business
Table 149. Lee Pharma Latest Developments
Table 150. Hanall Details, Company Type, Leuprolide Area Served and Its Competitors
Table 151. Hanall Leuprolide Product Offered
Table 152. Hanall Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. Hanall Main Business
Table 154. Hanall Latest Developments
Table 1. Leuprolide Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Leuprolide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Subcutaneous
Table 4. Major Players of Topical
Table 5. Leuprolide Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Leuprolide Market Size Market Share by Type (2020-2025)
Table 8. Leuprolide Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Leuprolide Market Size Market Share by Application (2020-2025)
Table 11. Global Leuprolide Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Leuprolide Revenue Market Share by Player (2020-2025)
Table 13. Leuprolide Key Players Head office and Products Offered
Table 14. Leuprolide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Leuprolide Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Leuprolide Market Size Market Share by Region (2020-2025)
Table 19. Global Leuprolide Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Leuprolide Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Leuprolide Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Leuprolide Market Size Market Share by Country (2020-2025)
Table 23. Americas Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Leuprolide Market Size Market Share by Type (2020-2025)
Table 25. Americas Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Leuprolide Market Size Market Share by Application (2020-2025)
Table 27. APAC Leuprolide Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Leuprolide Market Size Market Share by Region (2020-2025)
Table 29. APAC Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Leuprolide Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Leuprolide Market Size Market Share by Country (2020-2025)
Table 33. Europe Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Leuprolide Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Leuprolide Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Leuprolide Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Leuprolide
Table 39. Key Market Challenges & Risks of Leuprolide
Table 40. Key Industry Trends of Leuprolide
Table 41. Global Leuprolide Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Leuprolide Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Leuprolide Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Leuprolide Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. TOLMAR PHARMACEUTICALS Details, Company Type, Leuprolide Area Served and Its Competitors
Table 46. TOLMAR PHARMACEUTICALS Leuprolide Product Offered
Table 47. TOLMAR PHARMACEUTICALS Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. TOLMAR PHARMACEUTICALS Main Business
Table 49. TOLMAR PHARMACEUTICALS Latest Developments
Table 50. Sanofi Details, Company Type, Leuprolide Area Served and Its Competitors
Table 51. Sanofi Leuprolide Product Offered
Table 52. Sanofi Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sanofi Main Business
Table 54. Sanofi Latest Developments
Table 55. Teva Details, Company Type, Leuprolide Area Served and Its Competitors
Table 56. Teva Leuprolide Product Offered
Table 57. Teva Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Teva Main Business
Table 59. Teva Latest Developments
Table 60. Sandoz (Novartis) Details, Company Type, Leuprolide Area Served and Its Competitors
Table 61. Sandoz (Novartis) Leuprolide Product Offered
Table 62. Sandoz (Novartis) Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sandoz (Novartis) Main Business
Table 64. Sandoz (Novartis) Latest Developments
Table 65. Sun Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 66. Sun Pharmaceutical Leuprolide Product Offered
Table 67. Sun Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sun Pharmaceutical Main Business
Table 69. Sun Pharmaceutical Latest Developments
Table 70. AbbVie Details, Company Type, Leuprolide Area Served and Its Competitors
Table 71. AbbVie Leuprolide Product Offered
Table 72. AbbVie Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. AbbVie Main Business
Table 74. AbbVie Latest Developments
Table 75. Bayer Details, Company Type, Leuprolide Area Served and Its Competitors
Table 76. Bayer Leuprolide Product Offered
Table 77. Bayer Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Bayer Main Business
Table 79. Bayer Latest Developments
Table 80. Takeda Details, Company Type, Leuprolide Area Served and Its Competitors
Table 81. Takeda Leuprolide Product Offered
Table 82. Takeda Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Takeda Main Business
Table 84. Takeda Latest Developments
Table 85. Beijing Boente Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 86. Beijing Boente Pharmaceutical Leuprolide Product Offered
Table 87. Beijing Boente Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Beijing Boente Pharmaceutical Main Business
Table 89. Beijing Boente Pharmaceutical Latest Developments
Table 90. Livzon Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 91. Livzon Pharmaceutical Leuprolide Product Offered
Table 92. Livzon Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Livzon Pharmaceutical Main Business
Table 94. Livzon Pharmaceutical Latest Developments
Table 95. Selleck Details, Company Type, Leuprolide Area Served and Its Competitors
Table 96. Selleck Leuprolide Product Offered
Table 97. Selleck Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Selleck Main Business
Table 99. Selleck Latest Developments
Table 100. Hangzhou Peptide Biochemical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 101. Hangzhou Peptide Biochemical Leuprolide Product Offered
Table 102. Hangzhou Peptide Biochemical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Hangzhou Peptide Biochemical Main Business
Table 104. Hangzhou Peptide Biochemical Latest Developments
Table 105. Chengdu Shenguo Biological Pharmaceutical Details, Company Type, Leuprolide Area Served and Its Competitors
Table 106. Chengdu Shenguo Biological Pharmaceutical Leuprolide Product Offered
Table 107. Chengdu Shenguo Biological Pharmaceutical Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Chengdu Shenguo Biological Pharmaceutical Main Business
Table 109. Chengdu Shenguo Biological Pharmaceutical Latest Developments
Table 110. SciAnda Pharma Details, Company Type, Leuprolide Area Served and Its Competitors
Table 111. SciAnda Pharma Leuprolide Product Offered
Table 112. SciAnda Pharma Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. SciAnda Pharma Main Business
Table 114. SciAnda Pharma Latest Developments
Table 115. Daewoong Details, Company Type, Leuprolide Area Served and Its Competitors
Table 116. Daewoong Leuprolide Product Offered
Table 117. Daewoong Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Daewoong Main Business
Table 119. Daewoong Latest Developments
Table 120. GP Pharm Details, Company Type, Leuprolide Area Served and Its Competitors
Table 121. GP Pharm Leuprolide Product Offered
Table 122. GP Pharm Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. GP Pharm Main Business
Table 124. GP Pharm Latest Developments
Table 125. Enteris BioPharma Details, Company Type, Leuprolide Area Served and Its Competitors
Table 126. Enteris BioPharma Leuprolide Product Offered
Table 127. Enteris BioPharma Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Enteris BioPharma Main Business
Table 129. Enteris BioPharma Latest Developments
Table 130. Chong Kun Dang Details, Company Type, Leuprolide Area Served and Its Competitors
Table 131. Chong Kun Dang Leuprolide Product Offered
Table 132. Chong Kun Dang Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Chong Kun Dang Main Business
Table 134. Chong Kun Dang Latest Developments
Table 135. Leadiant Biosciences Details, Company Type, Leuprolide Area Served and Its Competitors
Table 136. Leadiant Biosciences Leuprolide Product Offered
Table 137. Leadiant Biosciences Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Leadiant Biosciences Main Business
Table 139. Leadiant Biosciences Latest Developments
Table 140. Hikma Pharmaceuticals Details, Company Type, Leuprolide Area Served and Its Competitors
Table 141. Hikma Pharmaceuticals Leuprolide Product Offered
Table 142. Hikma Pharmaceuticals Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Hikma Pharmaceuticals Main Business
Table 144. Hikma Pharmaceuticals Latest Developments
Table 145. Lee Pharma Details, Company Type, Leuprolide Area Served and Its Competitors
Table 146. Lee Pharma Leuprolide Product Offered
Table 147. Lee Pharma Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Lee Pharma Main Business
Table 149. Lee Pharma Latest Developments
Table 150. Hanall Details, Company Type, Leuprolide Area Served and Its Competitors
Table 151. Hanall Leuprolide Product Offered
Table 152. Hanall Leuprolide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. Hanall Main Business
Table 154. Hanall Latest Developments
LIST OF FIGURES
Figure 1. Leuprolide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Leuprolide Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Leuprolide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Leuprolide Sales Market Share by Country/Region (2024)
Figure 8. Leuprolide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Leuprolide Market Size Market Share by Type in 2024
Figure 10. Leuprolide in Breast Cancer
Figure 11. Global Leuprolide Market: Breast Cancer (2020-2025) & ($ millions)
Figure 12. Leuprolide in Endometriosis
Figure 13. Global Leuprolide Market: Endometriosis (2020-2025) & ($ millions)
Figure 14. Leuprolide in Precocious Puberty
Figure 15. Global Leuprolide Market: Precocious Puberty (2020-2025) & ($ millions)
Figure 16. Leuprolide in Prostate Cancer
Figure 17. Global Leuprolide Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 18. Leuprolide in Uterine Fibrosis
Figure 19. Global Leuprolide Market: Uterine Fibrosis (2020-2025) & ($ millions)
Figure 20. Leuprolide in Other
Figure 21. Global Leuprolide Market: Other (2020-2025) & ($ millions)
Figure 22. Global Leuprolide Market Size Market Share by Application in 2024
Figure 23. Global Leuprolide Revenue Market Share by Player in 2024
Figure 24. Global Leuprolide Market Size Market Share by Region (2020-2025)
Figure 25. Americas Leuprolide Market Size 2020-2025 ($ millions)
Figure 26. APAC Leuprolide Market Size 2020-2025 ($ millions)
Figure 27. Europe Leuprolide Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Leuprolide Market Size 2020-2025 ($ millions)
Figure 29. Americas Leuprolide Value Market Share by Country in 2024
Figure 30. United States Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Leuprolide Market Size Market Share by Region in 2024
Figure 35. APAC Leuprolide Market Size Market Share by Type (2020-2025)
Figure 36. APAC Leuprolide Market Size Market Share by Application (2020-2025)
Figure 37. China Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 41. India Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Leuprolide Market Size Market Share by Country in 2024
Figure 44. Europe Leuprolide Market Size Market Share by Type (2020-2025)
Figure 45. Europe Leuprolide Market Size Market Share by Application (2020-2025)
Figure 46. Germany Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 47. France Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Leuprolide Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Leuprolide Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa Leuprolide Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Leuprolide Market Size 2026-2031 ($ millions)
Figure 60. APAC Leuprolide Market Size 2026-2031 ($ millions)
Figure 61. Europe Leuprolide Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Leuprolide Market Size 2026-2031 ($ millions)
Figure 63. United States Leuprolide Market Size 2026-2031 ($ millions)
Figure 64. Canada Leuprolide Market Size 2026-2031 ($ millions)
Figure 65. Mexico Leuprolide Market Size 2026-2031 ($ millions)
Figure 66. Brazil Leuprolide Market Size 2026-2031 ($ millions)
Figure 67. China Leuprolide Market Size 2026-2031 ($ millions)
Figure 68. Japan Leuprolide Market Size 2026-2031 ($ millions)
Figure 69. Korea Leuprolide Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Leuprolide Market Size 2026-2031 ($ millions)
Figure 71. India Leuprolide Market Size 2026-2031 ($ millions)
Figure 72. Australia Leuprolide Market Size 2026-2031 ($ millions)
Figure 73. Germany Leuprolide Market Size 2026-2031 ($ millions)
Figure 74. France Leuprolide Market Size 2026-2031 ($ millions)
Figure 75. UK Leuprolide Market Size 2026-2031 ($ millions)
Figure 76. Italy Leuprolide Market Size 2026-2031 ($ millions)
Figure 77. Russia Leuprolide Market Size 2026-2031 ($ millions)
Figure 78. Egypt Leuprolide Market Size 2026-2031 ($ millions)
Figure 79. South Africa Leuprolide Market Size 2026-2031 ($ millions)
Figure 80. Israel Leuprolide Market Size 2026-2031 ($ millions)
Figure 81. Turkey Leuprolide Market Size 2026-2031 ($ millions)
Figure 82. Global Leuprolide Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global Leuprolide Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries Leuprolide Market Size 2026-2031 ($ millions)
Figure 1. Leuprolide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Leuprolide Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Leuprolide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Leuprolide Sales Market Share by Country/Region (2024)
Figure 8. Leuprolide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Leuprolide Market Size Market Share by Type in 2024
Figure 10. Leuprolide in Breast Cancer
Figure 11. Global Leuprolide Market: Breast Cancer (2020-2025) & ($ millions)
Figure 12. Leuprolide in Endometriosis
Figure 13. Global Leuprolide Market: Endometriosis (2020-2025) & ($ millions)
Figure 14. Leuprolide in Precocious Puberty
Figure 15. Global Leuprolide Market: Precocious Puberty (2020-2025) & ($ millions)
Figure 16. Leuprolide in Prostate Cancer
Figure 17. Global Leuprolide Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 18. Leuprolide in Uterine Fibrosis
Figure 19. Global Leuprolide Market: Uterine Fibrosis (2020-2025) & ($ millions)
Figure 20. Leuprolide in Other
Figure 21. Global Leuprolide Market: Other (2020-2025) & ($ millions)
Figure 22. Global Leuprolide Market Size Market Share by Application in 2024
Figure 23. Global Leuprolide Revenue Market Share by Player in 2024
Figure 24. Global Leuprolide Market Size Market Share by Region (2020-2025)
Figure 25. Americas Leuprolide Market Size 2020-2025 ($ millions)
Figure 26. APAC Leuprolide Market Size 2020-2025 ($ millions)
Figure 27. Europe Leuprolide Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Leuprolide Market Size 2020-2025 ($ millions)
Figure 29. Americas Leuprolide Value Market Share by Country in 2024
Figure 30. United States Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Leuprolide Market Size Market Share by Region in 2024
Figure 35. APAC Leuprolide Market Size Market Share by Type (2020-2025)
Figure 36. APAC Leuprolide Market Size Market Share by Application (2020-2025)
Figure 37. China Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 41. India Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Leuprolide Market Size Market Share by Country in 2024
Figure 44. Europe Leuprolide Market Size Market Share by Type (2020-2025)
Figure 45. Europe Leuprolide Market Size Market Share by Application (2020-2025)
Figure 46. Germany Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 47. France Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Leuprolide Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Leuprolide Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa Leuprolide Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Leuprolide Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Leuprolide Market Size 2026-2031 ($ millions)
Figure 60. APAC Leuprolide Market Size 2026-2031 ($ millions)
Figure 61. Europe Leuprolide Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Leuprolide Market Size 2026-2031 ($ millions)
Figure 63. United States Leuprolide Market Size 2026-2031 ($ millions)
Figure 64. Canada Leuprolide Market Size 2026-2031 ($ millions)
Figure 65. Mexico Leuprolide Market Size 2026-2031 ($ millions)
Figure 66. Brazil Leuprolide Market Size 2026-2031 ($ millions)
Figure 67. China Leuprolide Market Size 2026-2031 ($ millions)
Figure 68. Japan Leuprolide Market Size 2026-2031 ($ millions)
Figure 69. Korea Leuprolide Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Leuprolide Market Size 2026-2031 ($ millions)
Figure 71. India Leuprolide Market Size 2026-2031 ($ millions)
Figure 72. Australia Leuprolide Market Size 2026-2031 ($ millions)
Figure 73. Germany Leuprolide Market Size 2026-2031 ($ millions)
Figure 74. France Leuprolide Market Size 2026-2031 ($ millions)
Figure 75. UK Leuprolide Market Size 2026-2031 ($ millions)
Figure 76. Italy Leuprolide Market Size 2026-2031 ($ millions)
Figure 77. Russia Leuprolide Market Size 2026-2031 ($ millions)
Figure 78. Egypt Leuprolide Market Size 2026-2031 ($ millions)
Figure 79. South Africa Leuprolide Market Size 2026-2031 ($ millions)
Figure 80. Israel Leuprolide Market Size 2026-2031 ($ millions)
Figure 81. Turkey Leuprolide Market Size 2026-2031 ($ millions)
Figure 82. Global Leuprolide Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global Leuprolide Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries Leuprolide Market Size 2026-2031 ($ millions)
More Publications
Global Flush Hollow Metal Doors Market Growth 2025-2031
US$ 3,660.00
May 2025
123 pages
Global Botox Injection Market Growth 2024-2030
US$ 3,660.00
June 2024
99 pages
Global Active Wound Care Products Market Growth 2024-2030
US$ 3,660.00
June 2024
102 pages
Global Spine Surgery Products Market Growth 2025-2031
US$ 3,660.00
March 2025
131 pages
Global Ileostomy Products Market Growth 2025-2031
US$ 3,660.00
March 2025
106 pages
